Aromasin (25Mg)

Beligas Pharma Aromasin 25Mg / 30 Tabs contains research-grade Exemestane, a third-generation steroidal aromatase inhibitor (AI) designed for scientific exploration of estrogen suppression, testosterone recovery, and endocrine regulation.
Each tablet provides 25 mg of pharmaceutical-quality Exemestane, formulated under GMP-certified laboratory conditions to ensure precision and purity in aromatase inhibition and hormonal balance studies.

In performance and hormonal research, Beligas Aromasin 25 is recognized as a key reference compound for evaluating testosterone-to-estrogen ratio stabilization and post-cycle hormonal normalization.

How Exemestane Works

Exemestane functions as an irreversible aromatase enzyme inhibitor, blocking the conversion of androgens into estrogens.
In controlled research environments, Beligas Pharma Aromasin 25 allows scientists to:

• Measure enzyme inhibition kinetics and hormonal equilibrium,

• Evaluate testosterone retention and estrogen reduction,

• Analyze metabolic efficiency and lipid adjustments,

• Study long-term endocrine recovery models.

Its suicidal inhibition mechanism provides a sustained and consistent suppression effect—ideal for precise endocrine modulation studies.

Research & Performance Insight

In sports endocrinology and hormonal balance studies, Exemestane (Aromasin) is widely used to observe estrogen control and testosterone rebound following anabolic exposure.
Beligas Pharma Aromasin 25 supports investigations into:

• Aromatase enzyme resistance and inhibition duration,

• Hormonal recovery and androgenic balance,

• Estrogen rebound prevention,

• Metabolic adaptation during post-cycle conditions.

Its balanced pharmacokinetics make it valuable for research on long-term hormonal regulation and stability